CME Webcast Teaches on Antibiotic Stewardship

OSUWexnerbloglogo2014 CME Webcast Teaches on Antibiotic Stewardship. It seems that as fast as we invent new antibiotics, the bacteria are even faster at developing resistance to those antibiotics. And although we need new antibiotics, we also need to be more prudent in how we use the antibiotics that we already have, in order to minimize development of bacterial resistance. On this CME webcast, we’re going to hear about how hospitals can slow the development of bacterial antibiotic resistance and thus keep patients safer and keep their infections more treatable. Joining on moderator in the studio is Professor of Internal Medicine and the Medical Director of the Antimicrobial Stewardship Program at The Ohio State University, Dr. Kurt Stevenson.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the basics of antimicrobial resistance in the context of antimicrobial stewardship and explain why antimicrobial stewardship is critically important in our current climate; OUTLINE an overview of antimicrobial stewardship principles and discuss measures to avoid development of antimicrobial resistance; and DISCUSS examples of antimicrobial stewardship interventions and tools for clinicians.

You’ll also learn about the following:

  • Drug resistant bacteria
  • How to reduce antibiotic resistance
  • The Antimicrobial Stewardship Program at the OSU Wexner Medical Center
  • Antimicrobial stewardship in the ambulatory setting

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care

OSUWexnerbloglogo2014 On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care. On this CME webcast, we’re going to learn about the special needs of cancer survivors. We’re delighted to welcome medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and James Cancer Hospital, Dr. Maryam Lustberg. And also general internist, pediatrician, and Assistant Professor of Internal Medicine from OSU, Dr. Heather Saha.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the needs of cancer survivors throughout the cancer continuum; DISCUSS way to improve PCP and oncologist collaboration and communication.

You’ll also learn about the following:

  • The role of the primary care physician in cancer survivorship
  • Managing fatigue in the cancer survivor
  • Special considerations for survivors of pediatric cancers
  • Healthy diets for cancer survivors
  • Chemotherapy and peripheral neuropathy
  • Radiation effects on long-term health
  • Economic and financial implications of being a cancer survivor
  • Cancer survivors and sexual health
  • Cancers that can have late relapse

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Telemedicine on CME Webcast

OSUWexnerbloglogo2014 Learn About Telemedicine on CME Webcast. On this CME webcast, we’re going to show you some of the innovations in telemedicine and how it is being used in two specialties at The Ohio State University. First, to tell us about telepsychiatry is Assistant Professor of Psychiatry, Dr. Natalie Lester. And then to tell us about teledermatology is Assistant Professor of Internal Medicine, Dr. Benjamin Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the use of live-interactive telemedicine; RECOGNIZE advantages and pitfalls in this technology, using telepsychiatry as an example; UNDERSTAND the use of store-and-forward telemedicine; RECOGNIZE advantages and pitfalls in this technology, using dermatology as an example.

You’ll also learn about the following:

  • Efficacy of telepsychiatry
  • Obstacles in adapting telemedicine for dermatology
  • Using telepsychiatry with non-English speaking patients
  • Telepsychiatry in child and geriatric psychiatry
  • 2-D versus 3-D imaging
  • Other current applications of telemedicine at the Ohio State University

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Immunosuppressant Medications

OSUWexnerbloglogo2014 CME Webcast Teaches on Immunosuppressant Medications. More and more, primary care physicians and hospitalists are finding themselves taking care of patients who have been started on immunosuppressant medication a transplant physician, rheumatologist, nephrologist, or pulmonologist. On this CME webcast, we’re going to tell you what you need to know about these medications, their side effects, and their complications. Let me introduce our guests. Dr. Brian Keller is a lung transplant pulmonologist and Assistant Professor Internal Medicine at The Ohio State University. And Pamela Burcham is a lung transplant specialty pharmacist from the OSU Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS indications for immunosuppressive therapies; and DESCRIBE prophylaxis immunization, and pregnancy considerations for patients on Immunosuppressive therapy; UNDERSTAND the indications for individual immunosuppressants; and DESCRIBE the common adverse effects and monitoring parameters of the immunosuppressive medications.

You’ll also learn about the following:

  • Common indications for immunosuppressant medications
  • Commonly used immunosuppressant medications
  • Food safety for patients taking immunosuppressant medications
  • Pneumocystis jiroveci clinical presentation
  • Indications for TNF inhibitors
  • Infection risk of TNF inhibitors
  • Management of immunosuppressants in the perioperative period
  • Travel safety when taking an immunosuppressant
  • Bone health and corticosteroids
  • Eye health and corticosteroids
  • Monitoring for methotrexate-induced hepatotoxicity
  • Thiopurine methylytransferase
  • Cyclophosphamide

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Syncope On-line Enduring Material Teaches Primary Care Physicians

OSUWexnerbloglogo2014 Syncope On-line Enduring Material Teaches Primary Care Physicians. If you are a physician, you don’t have to be an emergency medicine doctor or a cardiologist to encounter syncope. On our webcast to tell us about the common causes of syncope and how to approach it diagnostically is hospitalist and Assistant Professor of Internal Medicine, Dr. Vijay Duggirala.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CREATE a high yield framework for clinicians to diagnose syncope; and IDENTIFY reasons for hospitalization and invasive testing in patients with syncope.

You’ll also learn about the following:

  • Common causes of syncope
  • Evaluation of the patient with syncope
  • Physical exam of the patient with syncope
  • What to look for on the EKG
  • Who needs an EEG
  • Admission versus observation status
  • What to tell patients to do when they have vasovagal prodromes
  • What to do if you witness syncope outside of the hospital
  • Medications causing syncope
  • Driving restrictions after syncope

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.